Blood disorder startup files for $86M IPO

As competitors narrow in, a blood disorder-focused Cambridge startup is planning to raise more funds through an IPO.

Imara Inc. hopes to raise $86M in its stock market launch, according to paperwork filed with the SEC. The company plans to trade on Nasdaq using the ticker “IMRA”.